EDGAR Filing Documents for 0001144204-17-057845

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001144204-17-057845

Filing Date

2017-11-09

Accepted

2017-11-09 17:28:54

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	tv478928_s3.htm	S-3	261064
2	EXHIBIT 1.2	tv478928_ex1-2.htm	EX-1.2	278066
3	EXHIBIT 4.5	tv478928_ex4-5.htm	EX-4.5	583284
4	EXHIBIT 5.1	tv478928_ex5-1.htm	EX-5.1	30635
5	EXHIBIT 12.1	tv478928_ex12-1.htm	EX-12.1	6363
6	EXHIBIT 23.1	tv478928_ex23-1.htm	EX-23.1	2797
7	EXHIBIT 23.2	tv478928_ex23-2.htm	EX-23.2	3139
8	GRAPHIC	tv478928_img1.jpg	GRAPHIC	12644
9	GRAPHIC	tv478928_img2.jpg	GRAPHIC	18053
10	GRAPHIC	tv478928_img3.jpg	GRAPHIC	14024
11	GRAPHIC	tv478928_img4.jpg	GRAPHIC	17199
12	GRAPHIC	image_001.jpg	GRAPHIC	3142
	Complete submission text file	0001144204-17-057845.txt		1256640

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014

Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366

Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)